Home > Formulary : Adult > Recent Decisions > 2019 >
Decisions 15th October 2019
At the meeting on the 15th October the following decisions were agreed
New Drug Requests
Approved
Opicapone (TLS Red)
-
As a second line option if Entacapone is ineffective or not tolerated.
-
Shared care protocol in development
-
Unfortunately, since the JFG meeting on 15th October, there has been a Supply Disruption Alert from DHSC issued on 25th October 2019 advising that Opicapone 50mg capsules will be out of stock from mid-November 2019 to mid-January 2020.
Safinamide (TLS Red)
Tapentadol (TLS Red)
-
for the management of moderate to severe acute pain (including severe acute on chronic pain) in adults where conventional opioids are unsuitable, under the acute pain service for a five day duration
Mycophenolate mofetil (oral) (TLS Red)
-
for the induction and maintenance treatment of autoimmune hepatitis for patients intolerant to thiopurines
Humalog Pre-filled pen KwikPen® 200units/ml® (TLS Blue)
Shared Care Protocols
New SCP: Melatonin for REM Sleep Disorder
Updated SCPs:
-
Colesevelam
-
Lacosamide
-
Oxcarbazepine
-
Pregablin
-
Roflumilast
-
Zonisamide
Further work needed
Bleomycin for vascular malformations
-
Further work needed by trust directorate
Opicapone
-
Shared care protocol and treatment pathway in development
Betamethasone soluble tablets for oral lichen planus
-
Further work needed on a guideline or SCP to support GPs with restarting subsequent courses of betamethasone to avoid repeated referrals back to secondary care for ongoing prescriptions